Constitutive activation of mTOR signaling pathway in post-transplant lymphoproliferative disorders
- 1 January 2007
- journal article
- Published by Elsevier in Laboratory Investigation
- Vol. 87 (1) , 29-39
Abstract
No abstract availableKeywords
This publication has 39 references indexed in Scilit:
- Synergistic effect of targeting mTOR by rapamycin and depleting ATP by inhibition of glycolysis in lymphoma and leukemia cellsLeukemia, 2005
- mTOR, translational control and human diseaseSeminars in Cell & Developmental Biology, 2005
- Sirolimus for pediatric liver transplant recipients with post‐transplant lymphoproliferative disease and hepatoblastoma*Pediatric Transplantation, 2004
- Mammalian target of rapamycin inhibition as therapy for hematologic malignanciesCancer, 2004
- Phosphorylation State-Specific AntibodiesThe American Journal of Pathology, 2003
- B cells under influence: transformation of B cells by Epstein–Barr virusNature Reviews Immunology, 2003
- Inactivation of the Tuberous Sclerosis Complex-1 and -2 Gene Products Occurs by Phosphoinositide 3-Kinase/Akt-dependent and -independent Phosphorylation of TuberinJournal of Biological Chemistry, 2003
- VIIa/Tissue Factor Interaction Results in a Tissue Factor Cytoplasmic Domain-independent Activation of Protein Synthesis, p70, and p90 S6 Kinase PhosphorylationJournal of Biological Chemistry, 2002
- Contraction Regulation of Akt in Rat Skeletal MuscleJournal of Biological Chemistry, 2002
- Ribosomal S6 Kinase Signaling and the Control of TranslationExperimental Cell Research, 1999